|
People with cancer are likely to accept the COVID-19 vaccine, but politics tracks with attitudes: An inspire and COSMO survey. |
|
|
Stock and Other Ownership Interests - InfiniteMD; NeuHope |
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; i-Mab; Regeneron; Tesaro |
Research Funding - Bristol-Myers Squibb (Inst); Kazia Therapeutics (Inst); Merck Sharp & Dohme (Inst); Tesaro (Inst) |
|
|
|
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - GlaxoSmithKline |
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Tesaro (Inst); VBL Therapeutics (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Blue Note Therapeutics; Rubedo Life Sciences |
|
|
|
Speakers' Bureau - Biopep Solution |
|
|
Stock and Other Ownership Interests - Doximity |
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AIM Specialty Health; Celgene; GlaxoSmithKline; GRAIL; Strata Oncology; Syapse; Takeda; VIA Oncology |
Research Funding - Abbvie (Inst); Amgen (Inst); ARMO BioSciences (Inst); Bristol-Myers Squibb (Inst); Cancer Research and Biostatistics (Inst); Denovo Biopharma (Inst); GlaxoSmithKline (Inst); Lynx Biosciences (Inst); PrECOG (Inst); Strata Oncology (Inst); Takeda (Inst); TG Therapeutics (Inst) |
Patents, Royalties, Other Intellectual Property - UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle) |
Travel, Accommodations, Expenses - GlaxoSmithKline; Syapse; Takeda |
Other Relationship - Doximity |